• 'Between pain and nothing, I choose nothing': trauma, post-traumatic stress disorder and substance use. Mills K.L., p. 1607-1609.
• Does smoking cue-induced craving tell us anything important about nicotine dependence? Perkins K.A., p. 1610-1616.
• Responses to smoking cues are relevant to smoking and relapse. Shiffman S., p. 1617-1618.
• The continuing conundrum of craving. Tiffany S.T., Wray J., p. 1618-1619.
• Cue-reactivity in rodents-how predictable? Shoaib M., p. 1619-1620.
• Cues must increase smoking behaviour to be clinically relevant. Perkins K.A., p. 1620-1622.
• Legislation to institutionalize resources for tobacco control: the 1987 Victorian Tobacco Act. Borland R., Winstanley M., Reading D., p. 1623-1629.
• Alcohol and Russian mortality: a continuing crisis. Leon D.A., Shkolnikov V.M., McKee M., p. 1630-1636.
• How confident should we be that smoking cessation treatments work? Hughes J.R., p. 1637-1640.
• The utility of online panel surveys versus computer-assisted interviews in obtaining substance-use prevalence estimates in the Netherlands. Spijkerman R., Knibbe R., Knoops K., Van De Mheen D., Van Den Eijnden R., p. 1641-1645.
• Cost-effectiveness of interventions to prevent alcohol-related disease and injury in Australia. Cobiac L., Vos T., Doran C., Wallace A., p. 1646-1655.
• Commentary on Cobiac et al. (2009): how to use science to improve alcohol policy? Rehm J., p. 1656-1657.
• 'I have no interest in drinking': a cross-national comparison of reasons why men and women abstain from alcohol use. Bernards S., Graham K., Kuendig H., Hettige S., Obot I., p. 1658-1668.
• Preventing heavy alcohol use in adolescents (PAS): cluster randomized trial of a parent and student intervention offered separately and simultaneously. Koning I.M., Vollebergh W.A., Smit F., Verdurmen J.E., Van Den Eijnden R.J., Ter Bogt T.F., et al., p. 1669-1678.
• Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study. Cottler L.B., Leung K.S., Abdallah A.B., p. 1679-1690.
• Preventing growth in amphetamine use: long-term effects of the Midwestern Prevention Project (MPP) from early adolescence to early adulthood. Riggs N.R., Chou C.P., Pentz M.A., p. 1691-1699.
• Subtypes of major depression in substance dependence. Niciu M.J., Chan G., Gelernter J., Arias A.J., Douglas K., Weiss R., et al., p. 1700-1709.
• First positive reactions to cannabis constitute a priority risk factor for cannabis dependence. Le Strat Y., Ramoz N., Horwood J., Falissard B., Hassler C., Romo L., et al., p. 1710-1717.
• Cigarettes and social differentiation in France: is tobacco use increasingly concentrated among the poor? Peretti-Watel P., Constance J., Seror V., Beck F., p. 1718-1728.
• Commentary on Peretti-Watel et al. (2009): the cost of a chronic disease. Dautzenberg B., p. 1729-1730.
• Interplay of Genetic Risk Factors and Parent Monitoring in Risk for Nicotine Dependence. Chen L.S., Johnson E.O., Breslau N., Hatsukami D., Saccone N.L., Grucza R.A., et al., p. 1731-1740.
• Commentary on Chen et al. (2009): gene-environment interactions in nicotine dependence. Kaprio J., p. 1741-1742.
• Adolescent smoking and depression: evidence for self-medication and peer smoking mediation. Audrain-McGovern J., Rodriguez D., Kassel J.D., p. 1743-1756.
• Startle cue-reactivity differentiates between light and heavy smokers. Rehme A.K., Frommann I., Peters S., Block V., Bludau J., Quednow B.B., et al., p. 1757-1764.
• Australian universities' open door policies on alcohol industry research funding. Kypri K., Walsh R.A., Sanson-Fisher R.W., p. 1765-1767.
• Topiramate and the question of dosage. Bergmark A., p. 1767-1768.